DOCSLIB.ORG

An Analysis of Myeloma Plasma Cell Phenotype Using Antibodies Defined at the Iird International Workshop on Human Leucocyte Differentiation Antigens

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
An Analysis of Myeloma Plasma Cell Phenotype Using Antibodies Defined at the Iird International Workshop on Human Leucocyte Differentiation Antigens Clin. exp. Immunol. (1988) 72, 351-356 An analysis of myeloma plasma cell phenotype using antibodies defined at the IIrd international workshop on human leucocyte differentiation antigens N. JACKSON, N.R. LING,* JENNIFER BALL, ELAINE BROMIDGE, P.D. NATHAN* & I.M. FRANKLIN Departments of Haematology and *Immunology, The Medical School, Birmingham (Acceptedfor publication 12 January 1988) SUMMARY Fresh bone marrow from 43 cases of myeloma and three cases of plasma cell leukaemia has been phenotyped both by indirect immune-rosetting and, on fixed cytospin preparations, by indirect immunofluorescence. Both clustered and unclustered B cell associated antibodies from the IIrd International Workshop on Human Leucocyte Differentiation Antigens were used. The results confirm the lack of many pan-B antigens on the surface of myeloma plasma cells, i.e. CD19-23, 37, 39, w40. Strong surface reactivity is seen with CD38 antibodies and with one CD24 antibody (HB8). Weak reactions are sometimes obtained with CD9, 10 and 45R. On cytospin preparations CD37, 39 and w40 are sometimes weakly positive, and anti-rough endoplasmic reticulum antibodies are always strongly positive. Specific and surface-reacting antiplasma cell antibodies are still lacking. Keywords myeloma phenotype antibody cluster INTRODUCTION antibodies from CD24 (HB8 and VIB-E3). Before and after the IIrd workshop, we carried out a phenotypic analysis of fresh Multiple myeloma (MM) is a neoplastic disorder of the B cell MM bone marrow cells using both clustered and unclustered lineage. It is characterized by an excess ofneoplastic plasma cells monoclonal antibodies (MoAb) supplied for the workshop, in the bone marrow, although the nature of the clonogenic cell including one from each ofthe new and the previously defined B remains uncertain. On terminal differentiation to plasma cells, cell associated clusters. Some of these results were presented at cells of the B lineage cease to express many characteristic B cell the Workshop (Nathan et al., 1987). antigens. These include antigens detected by antibodies of clusters CD19-23 as defined at the 1Ind International Work- shop on Human Leucocyte Differentiation Antigens (Nadler, METHODS AND PATIENTS 1986) and surface immunoglobulin (sIg) (Katagiri et al., 1984; Foon, Schroff & Gale, 1982). The majority of plasma cells also Patients lack major histocompatibility complex (MHC) class II antigens Forty-six patients who fulfilled the Medical Research Council (Wu et al., 1976; Kuritani & Cooper 1982; Katagiri et al., 1984), criteria for entry into the IVth Myelomatosis trial (Medical and Fc and C3 receptors (Stashenko et al., 1980). Recently, Research Council, 1985) were studied, including three with some cases of myeloma have been found to express CDIO plasma cell leukaemia (i.e. peripheral blood plasma cell count (CALLA; common acute lymphoblastic leukaemia antigen) on .2 x 109/1). Their paraprotein type and treatment status are some of the cells in blood and bone marrow (Ruiz-Arguelles et shown in Table 1. al., 1984; Durie & Grogan, 1985; Caligaris-Cappio et al., 1985). The I1Ird International Workshop (McMichael et al., 1987) Surface antigen detection: indirect immune-rosetting defined five new B cell associated antibody clusters (CD 37-w40 Indirect immune-rosetting was used for surface antigen detec- and 45R), and also included studies on other antibodies which tion, a technique well established in this laboratory (Ling, were not clustered but which were found to react with plasma Bishop & Jefferis, 1977; Kalland, 1977). The MoAb, as listed in cells. Plasma cell reactivity was tested mainly against plasmacy- Table 2, were diluted (1 Ml in 50 pi of phosphate-buffered saline toid cell lines (JVM-3, U-266, HFB-1, RPMI-8226). Cells from (PBS) containing 10% fetal calf serum (FCS) and 0-1 % sodium only two cases of MM were investigated and they showed azide. An anti-idiotype MoAb generated against an unrelated moderate reactivity with antibodies of CD38, CD39 and two myeloma paraprotein was used as a control. Then, 2 5 x I05 cells to be analysed were added (in 5-20 p1 of culture medium) and Correspondence: Dr N. Jackson, Department of Haematology, incubated at 4°C for 30 min. After washing twice in Hepes- Royal Free Hospital, Pond Street, London NW3 2QG, UK. buffered RPMI 1640 medium with 2% FCS, the cells were mixed 351 352 N. Jackson et al. with approximately 10 x 106 sheep erythrocytes coated with a Table 1. Patient characteristics with their paraprotein sheep anti-mouse immunoglobulin in 150 p1 of the same types medium. This mixture was left to stand at room temperature for 10 min, centrifuged at 100 g for 30 s, and left to stand for a Myeloma Plasma cell leukaemia further 10 min. One drop of Acridine Orange (18 75 pg/ml) was added and after gently resuspending the cells, one drop was Paraprotein Untreated Treated Untreated spread under a coverslip on a multi-spot Polytetrafluoroethy- lene-coated slide. The percentage of rosetted non-myeloid cells IgG 15 11 1 was enumerated by counting the number of white cells with at IgA 4 7 2 least four SRBC attached out of a total of 100 or 200 cells. A Light chain 1 5 fluorescence microscope (Leitz dialux, Leitz Instruments, Bed- only ford UK) was used, set for Fluorescein excitation by epi- illumination to visualize the fluorescing nuclei, with slight background illumination with ordinary light to visualize the Cytoplasmic antigen detection: indirect immunofluorescence erythrocytes. As Acridine Orange makes myeloid cell cytoplasm Approximately 1-2 x 105 cells were cytospun onto slides, and fluoresce red under these circumstances, these cells were elimi- fixed in acetone for 10 min. The slide was first incubated with 1 nated from the counting in order to concentrate on the plasma p1 ofMoAb in 50 pi PBS with 10% FCS at room temperature for cells, which were also recognized by their characteristic morpho- 30 min, and then washed for 30 min in PBS. The slide was then logy. However, this led to some other non-myeloid cells being incubated with a I-in-100 dilution of fluorescein-conjugated counted, e.g. lymphocytes. Hence, small percentage values sheep anti-mouse Ig (prepared in this department by Dr G. D. (< 10%) were regarded as negative; counts between 10-30% as Johnson) for 30 min, and washed in PBS for 30 min. The slides weak positivity of plasma cells with that antibody; counts were then dipped in propidium iodide (1 pg/ml) for 5 min for > 30% as definite positivity with that antibody. nuclear counterstaining, and mounted using polyvinyl alcohol Table 2. Antibodies used, their cluster designation (CD) where applicable, and the sources from which they were obtained Antibody CD Source control An anti-idiotype MoAb produced in the Immunology lab, Birmingham University BU 16 9 Immunology lab, Birmingham University Anti-CALLA 10 Becton-Dickinson* BU12 19 Immunology lab, Birmingham University BCI 20 Gallart, Barcelona BA5 21 Le Bien, Minnesota 29-110 22 Kraft, Melbourne MHM6 23 McMichael, Oxford ALB9 24 Boucheix, Villejuif, France HB8 24 Cooper, Alabama HB9 24 Cooper, Alabama VIB C5 24 Knapp, Vienna VIB E3 24 Knapp, Vienna ALIa 24 Ravoet, Brussels LC66 24 Ravoet, Brussels CLB/granBly I 24 Tetteroo, Amsterdam Anti-IL2 receptor 25 Becton-Dickinson* WR-17 37 Moore, Southampton OKTIO 38 American Type Culture Collection HB7 38 Tedder, Boston T16 38 Bourel, Rennes, France T168 38 Bourel, Rennes, France AC2 39 Rowe, Birmingham G28.5 w40 Ledbetter, Seattle 4KB5 45R Pulford, Oxford PCA-l Nadler, Boston BU25 Anti-MHC class II Immunology lab, Birmingham University KB61 Pulford, Oxford 7F7 Schulz, Innsbruck BU 11,18 Anti-RER Immunology lab, Birmingham University RFD6 Anti-RER Janossy, London * Purified antibody; others were ascitic fluid. Myeloma phenotype 353 WeaNs | W*-90r-.ve positive 1_ Definitely positiVe CD 10 20 30 40 50 60 70 80 90 100 _~~~,.~~ I 9 V 10 ,i Dea so l 19 20 I 21 I t 22 la I 23 I 24 (HB8) 24 (except HB8) s 25 o3 , 37 38 39 w40 it 45R Fig. 1. Surface reactivity ofmyeloma plasma cells with clustered antibodies: percentage ofpositive cells by indirect immune-rosetting. (0) Untreated; (0) treated; CD, cluster designation. with 1, 4-diazobicyclo-(2,2,2)-octane (Johnson et al., 1982). The Table 3. Cytoplasmic reactivity of myeloma slides were examined using a fluorescence microscope set for plasma cells with clustered antibodies fluorescein excitation (fluorescein, green; propidium iodide, red), and results graded as negative, weak, moderate, or strong. Cytoplasmic reactivity This method will also stain surface antigens that are not destroyed by acetone fixation. CD No. Negative Weak Moderate Strong 9 1 8 I RESULTS 10 8 2 19 6 4 20 8 Reactivity ofmyeloma plasma cells with clustered antibodies 21 6 Bone marrow mononuclear cells from 46 patients have been 22 9 1 analysed with various combinations of antibodies. The 16 most 23 4 2 recent samples have been tested against the full spread of B cell 24 (HB8) 6 6 2 24 (other) 6 antibody clusters, as defined by the IlIrd International Work- 25 12 shop. The results for antibodies from these clusters are shown in 37 7 1 Fig. 1 (surface typing), and Table 3 (cytoplasmic typing). In the 38 6 11 13 majority of cases the plasma cells were HB8+, but most other 39 5 3 antibodies from CD24 gave negative results. Most cases (26/36) 40 3 3 I were CD38 (OKT10)+, but some were negative by indirect resetting. In eight out of the 10 CD38- cases, the pattern of CD, cluster designation. positivity ofthe immunofluorescence on the cytospins suggested that the cells were in fact surface CD38+. One case was CDl0+ CDl9+, CD20+, and CD23+, and occasional weak surface Reactivity ofmyeloma plasma cells with unclustered antibodies reactivity was also obtained with CD9 (three cases), CD25 (two The results using unclustered antibodies are shown in Fig.
Load more

Recommended publications
  • Modelling the Affinity Maturation of B Lymphocytes in the Germinal Centre
    Modelling the Affinity Maturation of B Lymphocytes in the Germinal Centre By ADAM THOMAS REYNOLDS A thesis submitted to The University of Birmingham for the degree of MASTER OF PHILOSOPHY School of Biosciences The University of Birmingham June 2010 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. To my Mum and Dad Acknowledgments I would like to thank all the people who have helped me directly and indirectly during this research project and helped me make this a memorable experience. I would like to thank Francesco Falciani, Kai Tollener, Mike Salmon, Micheal Hermann and Dov Stekel for technical support and guidance. I would also like to thank the BBSRC for providing funding for this thesis and thank Illogic for providing a licence to use the Rhapsody tool. I would also like to thank Antony Pemberton for help and support in the use of the Birmingham Biosciences High Performance Computer Cluster to perform the many computer simulations and to thank Ruth Harrison and the student support services who where invaluable in providing support and help with this thesis.
    [Show full text]
  • Does Recycling in Germinal Centers Exist?
    Does Recycling in Germinal Centers Exist? Michael Meyer-Hermann Institut f¨ur Theoretische Physik, TU Dresden, D-01062 Dresden, Germany E-Mail: [email protected] Abstract: A general criterion is formulated in order to decide if recycling of B-cells exists in GC reactions. The criterion is independent of the selection and affinity maturation process and based solely on total centroblast population arguments. An experimental test is proposed to verify whether the criterion is fulfilled. arXiv:physics/0102062v2 [physics.bio-ph] 6 Mar 2002 1 1 Introduction The affinity maturation process in germinal center (GC) reactions has been well charac- terized in the last decade. Despite a lot of progress concerning the morphology of GCs and the stages of the selection process, a fundamental question remains unsolved: Does recycling exist? Recycling means a back differentiation of antibody presenting centrocytes (which undergo the selection process and interact with antigen fragments or T-cells) to centroblasts (which do not present antibodies and therefore do not interact with antigen fragments but proliferate and mutate). The existence of recycling in the GC has important consequences for the structure of the affinity maturation process in GC reactions. The centroblasts proliferate and mutate with high rates in the environment of follicular dendritic cells. During the GC reaction they differentiate to antibody presenting centrocytes which may then be selected by inter- action with antigen fragments and T-cells. If the positively selected centrocytes recycle to (proliferating and mutating) centroblasts the antibody-optimization process in GCs may be compatible with random mutations of the centroblasts.
    [Show full text]
  • Lymph Node Cytology
    Lymph node cytopathology : A practical approach to lymphoproliferative disorders • Koray Ceyhan, M.D • Department of Pathology • Faculty of Medicine • Ankara University • Ankara, Turkey Diagnostic use of FNA in lymph node pathologies • Well-established : • - metastatic malignancy, • - lymphoma recurrences • -some reactive or inflammatory disorders: Tuberculosis,sarcoidosis • Diagnostic sensitivity/accuracy : usually above 95% • Controversial: • primary lymphoma diagnosis • Diagnostic sensitivity varies from 12% to 96% Academic institutions: high level diagnostic accuracy Community practise the accuracy rate significantly low Multiparameter approach is critical for definitive lymphoma diagnosis • Cytomorphologic features alone are not sufficient for the diagnosis of primary lymphoma • Immunophenotyping with flow cytometry and/or immunocytochemistry is mandatory • In selected cases molecular/cytogenetic analyses are required for definitive lymphoma classification Lymph node pathologies • 1-Reactive lymphoid hyperplasia/inflammatory disorders • 2-Lymphoid malignancies • 3-Metastatic tumors 1 3 2 Common problems in lymph node cytology • Reactive lymphoid hyperplasia vs lymphoma • Primary lymphoma diagnosis(lymphoma subtyping) • Predicting primary site of metastatic tumor • Nonlymphoid tumors mimicking lymphoid malignancies • Correct diagnosis of specific benign lymphoid lesions Problem 1: Reactive vs lymphoma Case 19- years-old boy Multiple bilateral cervical LAPs for 4 weeks FNA from the largest cervical lymph node measuring 15X13 mm No
    [Show full text]
  • A Mathematical Model for the Germinal Center Morphology and Affinity
    A mathematical model for the germinal center morphology and affinity maturation Michael Meyer-Hermann Institut f¨ur Theoretische Physik, TU Dresden, D-01062 Dresden, Germany E-Mail: [email protected] Abstract: During germinal center reactions the appearance of two specific zones is ob- served: the dark and the light zone. Up to now, the origin and function of these zones are poorly understood. In the framework of a stochastic and discrete model several possi- ble pathways of zone development during germinal center reactions are investigated. The importance of the zones in the germinal center for affinity maturation, i.e. the process of antibody optimization is discussed. arXiv:physics/0203021v1 [physics.bio-ph] 7 Mar 2002 1 1 Introduction Germinal centers (GC) are an important part of the humoral immune response. They develop after the activation of B-cells by antigens. Such activated B-cells migrate into the follicular system where they begin a monoclonal expansion in the environment of follicular dendritic cells (FDC). This phase of pure centroblast multiplication is followed by a phase of intense hypermutation and proliferation which leads to a larger repertoire of different centroblast types. This seems to be the basis of the affinity maturation process, i.e. the optimization process of the antibodies with respect to a given antigen during germinal center reactions. Antigen fragments are presented on the surface of the FDCs which enables antibody presenting cells to interact with them. It is widely believed that centroblasts do not present antibodies (Han et al., 1997). Accordingly, the selection process must begin after the differentiation of centroblasts to centrocytes (the initiation of this differentiation process is still unclear) which do neither proliferate nor mutate but which present antibodies.
    [Show full text]
  • 7432.Full.Pdf
    CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation This information is current as Yanling Xiao, Jenny Hendriks, Petra Langerak, Heinz Jacobs of September 29, 2021. and Jannie Borst J Immunol 2004; 172:7432-7441; ; doi: 10.4049/jimmunol.172.12.7432 http://www.jimmunol.org/content/172/12/7432 Downloaded from References This article cites 43 articles, 23 of which you can access for free at: http://www.jimmunol.org/content/172/12/7432.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation1 Yanling Xiao, Jenny Hendriks, Petra Langerak, Heinz Jacobs, and Jannie Borst2 Studies on human B cells have featured CD27 as a marker and mediator of the B cell response.
    [Show full text]
  • Activation-Induced Cytidine Deaminase (AID)- Dependent Somatic Hypermutation Requires a Splice Isoform of the Serine/Arginine-Rich (SR) Protein SRSF1
    Activation-induced cytidine deaminase (AID)- dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1 Yuichi Kanehiroa,1,2, Kagefumi Todoa,1,3, Misaki Negishia, Junji Fukuokaa, Wenjian Ganb, Takuya Hikasaa, Yoshiaki Kagaa, Masayuki Takemotoa, Masaki Magaria, Xialu Lib, James L. Manleyc,4, Hitoshi Ohmoria,4, and Naoki Kanayamaa,4 aDepartment of Bioscience and Biotechnology, Okayama University Graduate School of Natural Science and Technology, Tsushima-Naka, Kita-Ku, Okayama 700-8530, Japan; bNational Institute of Biological Sciences, Beijing 102206, People’s Republic of China; and cDepartment of Biological Science, Columbia University, New York, NY 10027 Contributed by James L. Manley, December 12, 2011 (sent for review October 9, 2011) Somatic hypermutation (SHM) of Ig variable region (IgV) genes DNAs harboring SHM hotspot motifs, thus enabling AID-me- requires both IgV transcription and the enzyme activation-induced diated deamination (8, 23–25). In addition, it has recently been cytidine deaminase (AID). Identification of a cofactor responsible reported that depletion of the THO-TREX complex, which for the fact that IgV genes are much more sensitive to AID-induced functions as the interface between transcription and mRNA ex- mutagenesis than other genes is a key question in immunology. port, enhances mutation in AID-expressing yeast cells (26). Here, we describe an essential role for a splice isoform of the pro- However, cofactors that are essential for generating and stabi- lizing ssDNA bubbles in the IgV genes in vivo are not well de- totypical serine/arginine-rich (SR) protein SRSF1, termed SRSF1-3, fi in AID-induced SHM in a DT40 chicken B-cell line.
    [Show full text]
  • Allergy and Immunology Review Corner: Chapter 9 of Janeway’S Immunobiology 8Th Edition by Kenneth Murphy
    Allergy and Immunology Review Corner: Chapter 9 of Janeway’s Immunobiology 8th Edition by Kenneth Murphy. Chapter 9 (pages 335-381): T Cell-Mediated Immunity Prepared by Amanda Jagdis, MD, University of Toronto and Monica Bhagat, MD, University of Pennsylvania 1. What is the correct sequence of lymphocyte entry into lymph nodes? A. Diapedesis; entry into the high endothelial venule; binding of L-selectin to GlyCAM-1; binding of LFA-1 to ICAM-1 B. Entry into the high endothelial venule; diapedesis; binding of LFA-1 to ICAM-1; binding of L-selectin to Gly-CAM-1 C. Entry into the high endothelial venule; binding of LFA-1 to ICAM-1; binding of L-selectin to Gly-CAM-1; diapedesis D. Entry into the high endothelial venule; binding of L-selectin to Gly-CAM-1; binding of LFA-1 to ICAM-1; diapedesis 2. What are the costimulatory molecules expressed by antigen presenting cells (APC’s) that are required for activation (second signal) of naive T cells? A. MHC2 B. B7.1/B7.2 C. IL-12 D. CD28 3. Which of the following binds B7 and results in inhibition? A. CTLA-4 B. CD28 C. CD70 D. ICOS 4. What cytokines are produced by TH1 cells? A. A. IL-4, IL-5 B. IL-6, IL-17 C. IL-2 and IFNγ D. IL-10, TGF-B 5. Which of the following transcription factors is involved in development of Treg cells? A. FoxP3 B. GATA3 C. Tbet D. Bcl6 6. In the recirculation of T cells, which of the following lymphoid organs does not utilize efferent lymphatics to exit from the organ? A.
    [Show full text]
  • B Cells Centrocytes Within Human Germinal Center Discriminates
    CXCR4 Expression Functionally Discriminates Centroblasts versus Centrocytes within Human Germinal Center B Cells This information is current as of September 28, 2021. Gersende Caron, Simon Le Gallou, Thierry Lamy, Karin Tarte and Thierry Fest J Immunol 2009; 182:7595-7602; ; doi: 10.4049/jimmunol.0804272 http://www.jimmunol.org/content/182/12/7595 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2009/06/02/182.12.7595.DC1 Material http://www.jimmunol.org/ References This article cites 27 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/182/12/7595.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 28, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CXCR4 Expression Functionally Discriminates Centroblasts versus Centrocytes within Human Germinal Center B Cells1 Gersende Caron,2*† Simon Le Gallou,2* Thierry Lamy,*‡ Karin Tarte,*† and Thierry Fest3*† The human germinal center is a highly dynamic structure where B cells conduct their terminal differentiation and traffic following chemokine gradients.
    [Show full text]
  • TGF-B Induces Apoptosis in Human B Cells by Transcriptional Regulation of BIK and BCL-XL
    Cell Death and Differentiation (2009) 16, 593–602 & 2009 Macmillan Publishers Limited All rights reserved 1350-9047/09 $32.00 www.nature.com/cdd TGF-b induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL LC Spender*,1, DI O’Brien1, D Simpson2, D Dutt1, CD Gregory3, MJ Allday4, LJ Clark5 and GJ Inman*,1 Transforming growth factor-b (TGF-b) potently induces apoptosis in Burkitt’s lymphoma (BL) cell lines and in explanted primary human B lymphocytes. The physiological relevance and mechanism of TGF-b-mediated apoptosis induction in these cells remains to be determined. Here we demonstrate the requirement for TGF-b-mediated regulation of BIK and BCL-XL to activate an intrinsic apoptotic pathway in centroblastic BL cells. TGF-b directly induced transcription of BIK and a consensus Smad-binding element identified in the BIK promoter recruits TGF-b-activated Smad transcription factor complexes in vivo. TGF-b also transcriptionally repressed expression of the apoptosis inhibitor BCL-XL. Inhibition of BCL-XL sensitised BL cells to TGF-b- induced apoptosis whereas overexpression of BCL-XL or suppression of BIK by shRNA, diminished TGF-b-induced apoptosis. BIK and BCL-XL were also identified as TGF-b target genes in purified normal human centroblast B cells and immunohistochemical analyses of tonsil tissue revealed widespread TGF-b receptor-regulated Smad activation and a focal pattern of BIK expression. Furthermore, using a selective inhibitor of the TGF-b receptor we provide evidence that autocrine TGF-b signalling through ALK5 contributes to the default apoptotic programme in normal human centroblasts undergoing spontaneous apoptosis.
    [Show full text]
  • Centroblasts in Vivo the A-Myb Transcription Factor Is a Marker Of
    The A-Myb Transcription Factor Is a Marker of Centroblasts In Vivo Josée Golay, Vania Broccoli, Giuseppe Lamorte, Carlo Bifulco, Carlo Parravicini, Arnold Pizzey, N. Shaun B. Thomas, Domenico This information is current as Delia, Paola Ferrauti, Domenico Vitolo and Martino Introna of October 4, 2021. J Immunol 1998; 160:2786-2793; ; http://www.jimmunol.org/content/160/6/2786 Downloaded from References This article cites 47 articles, 18 of which you can access for free at: http://www.jimmunol.org/content/160/6/2786.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 4, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The A-Myb Transcription Factor Is a Marker of Centroblasts In Vivo1 Jose´e Golay,2* Vania Broccoli,* Giuseppe Lamorte,† Carlo Bifulco,‡ Carlo Parravicini,‡ Arnold Pizzey,§ N. Shaun B. Thomas,§ Domenico Delia,¶ Paola Ferrauti,i Domenico Vitolo,i and Martino Introna* The A-Myb transcription factor is structurally related to the c-myb proto-oncogene and is involved in the control of proliferation and/or differentiation of mature B lymphocytes.
    [Show full text]
  • IL-21 Acts As a Promising Therapeutic Target in Systemic Lupus Erythematosus by Regulating Plasma Cell Differentiation
    Cellular & Molecular Immunology (2015) 12, 31–39 ß 2015 CSI and USTC. All rights reserved 1672-7681/15 $32.00 www.nature.com/cmi REVIEW IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation Xiao-Mei Deng, Shang-Xue Yan and Wei Wei Plasma cells, which secrete auto-antibodies, are considered to be the arch-criminal of autoimmune diseases such as systemic lupus erythematosus, but there are many cytokines involved in inducing the differentiation of B-cell subsets into plasma cells. Here, we emphasize IL-21, which has emerged as the most potent inducer of plasma cell differentiation. In this review, we focused on the promoting effects of IL-21 on plasma cell differentiation and discuss how these effects contribute to B cell-mediated autoimmune disease. Cellular & Molecular Immunology (2015) 12, 31–39; doi:10.1038/cmi.2014.58; published online 4 August 2014 Keywords: Bcl-6; Blimp-1; IL-21; plasma cell; systemic lupus erythematosus INTRODUCTION whereby they further differentiate into marginal zone or follic- Plasma cells (PCs), which act as double-edged swords in the ular B cells.8,9 When activated in the secondary lymphoid immune system, are the unique source of auto-antibodies in organs, marginal zone B cells expand and differentiate into autoimmune diseases such as systemic lupus erythematosus short-lived PCs, which rapidly undergo apoptosis to exert a (SLE). Accumulation of auto-reactive PCs and auto-antibod- rapid and temporary protection of organs.10–12 Together, mar- ies1,2 has been reported in SLE patients and murine models.
    [Show full text]
  • Follicular Lymphoma Biology and Pathology Update Partially
    Follicular Lymphoma Biology and Pathology Update Partially Fan Zhou, MD, PhD, FCAP PeaceHealth Laboratory Vancouver PeaceHealth Southwest Medical Center Vancouver, WA 98668 Department of Pathology PeaceHealth Southwest Medical Center Fan Zhou, MD, PhD. Vancouver, WA 98668 Lymphoma Classification Tumor Board Follicular Lymphoma Diagnosis Pathology Diagnostic tasks: Classification of disease Stratification of prognosis Identification of therapeutic targets Evaluation of treatment outcome Department of Pathology PeaceHealth Southwest Medical Center Fan Zhou, MD, PhD. Vancouver, WA 98668 Follicular Lymphoma Protype of Low Grade B-cell Lymphoma Department of Pathology PeaceHealth Southwest Medical Center Fan Zhou, MD, PhD. Vancouver, WA 98668 Follicular Lymphoma Diagnosis Definition of Follicular Lymphoma Lymphoma of follicular centrocytes and centroblasts Immunoprofile: CD20+, CD10+, CD5-, CD23-, Bcl2+, Bcl6+ Molecular and Genetic: t(14;18) and bcl-2 over-expression Variable histologic patterns with most of them showing more or less a follicular pattern. Department of Pathology PeaceHealth Southwest Medical Center Fan Zhou, MD, PhD. Vancouver, WA 98668 Follicular Lymphoma Overview The second most common B-cell lymphoma FL accounts about 20% of all lymphomas with the highest incidence in US and Western Europe. FL affects predominantly adults with a mean age of 60. FL slightly affects more females (M:F ratio of 1:1.7). FL Involves mostly lymph nodes. BM involvement 40-70%. Most of the patient in advanced stages at diagnosis and only a third in stage I & II. Most patients progress to DLBCL, about 3% per year. Most of the FL patients are asymptomatic and 20% have spontaneous regression. Easy diagnosis with the highest agreement rate. Department of Pathology PeaceHealth Southwest Medical Center Fan Zhou, MD, PhD.
    [Show full text]